Listening for Early Signs of Alzheimer’s Disease #ASA187

Listening for Early Signs of Alzheimer’s Disease #ASA187

In-ear microphones could monitor sounds of eye movements for neurological decay.

Media Contact:
AIP Media
301-209-3090
media@aip.org

MELVILLE, N.Y., Nov. 19, 2024 – Alzheimer’s disease affects more than 50 million people worldwide, often devastating both the individuals who have it and their families and loved ones. It has no known cure, and the slow, progressive nature of the disease makes early diagnosis difficult.

Researchers from École de Technologie Supérieure and Dartmouth University are investigating the use of earpiece microphones to spot early signs of Alzheimer’s. Miriam Boutros will present their work on Tuesday, Nov. 19, at 4:15 p.m. ET, as part of the virtual 187th Meeting of the Acoustical Society of America, running Nov. 18-22, 2024.

People with Alzheimer’s exhibit a loss of motor control along with cognitive decline. One of the earliest signs of this decay can be spotted in involuntary eye movements known as saccades. These quick twitches of the eyes in Alzheimer’s patients are often slower, less accurate, or delayed compared to those in healthy individuals.

Alzheimer's

The researchers will track abnormal saccades, an early sign of Alzheimer’s, using both eye-tracking technology and in-ear hearables. Credit: Boutros et al.

“Eye movements are fascinating since they are some of the most rapid and precise movements in the human body, thus they rely on both excellent motor skills and cognitive functioning,” said researcher Arian Shamei.

Detecting and analyzing saccades directly requires a patient to be monitored by eye-tracking equipment, which is not easily accessible for most people. Boutros and her colleagues are exploring an alternative method using a more ubiquitous and less intrusive technology: earpiece microphones. This research is led by Rachel Bouserhal at the Research in Hearing Health and Assistive Devices (RHAD) Laboratory at École de Technologie Supérieure and Chris Niemczak at the Geisel School of Medicine at Dartmouth University.

“We are using a device called a hearable,” said Boutros. “It is an earpiece with in-ear microphones that captures physiological signals from the body. Our goal is to develop health-monitoring algorithms for hearables, capable of continuous, long-term monitoring and early disease detection.”

Eye movements, including saccades, cause eardrum vibrations that can be picked up by sensitive microphones located within the ear. The researchers are conducting experiments with volunteers, giving them both hearables and conventional eye trackers. Their goal is to identify signals corresponding to saccades, and to differentiate between healthy signals and others that are indicative of neurological disorders like Alzheimer’s.

They hope one day their research will lead to devices that can perform noninvasive continuous monitoring for Alzheimer’s along with other neurological diseases.

“While the current project is focused on long-term monitoring of Alzheimer’s disease, eventually, we would like to tackle other diseases and be able to differentiate between them based on symptoms that can be tracked through in-ear signals,” said Shamei.

———————– MORE MEETING INFORMATION ———————–
​Main Meeting Website: https://acousticalsociety.org/asa-virtual-fall-2024/
Technical Program: https://eppro01.ativ.me/src/EventPilot/php/express/web/planner.php?id=ASAFALL24

ASA PRESS ROOM
In the coming weeks, ASA’s Press Room will be updated with newsworthy stories and the press conference schedule at https://acoustics.org/asa-press-room/.

LAY LANGUAGE PAPERS
ASA will also share dozens of lay language papers about topics covered at the conference. Lay language papers are summaries (300-500 words) of presentations written by scientists for a general audience. They will be accompanied by photos, audio, and video. Learn more at https://acoustics.org/lay-language-papers/.

PRESS REGISTRATION
ASA will grant free registration to credentialed and professional freelance journalists. If you are a reporter and would like to attend the virtual meeting and/or press conferences, contact AIP Media Services at media@aip.org. For urgent requests, AIP staff can also help with setting up interviews and obtaining images, sound clips, or background information.

ABOUT THE ACOUSTICAL SOCIETY OF AMERICA
The Acoustical Society of America is the premier international scientific society in acoustics devoted to the science and technology of sound. Its 7,000 members worldwide represent a broad spectrum of the study of acoustics. ASA publications include The Journal of the Acoustical Society of America (the world’s leading journal on acoustics), JASA Express Letters, Proceedings of Meetings on Acoustics, Acoustics Today magazine, books, and standards on acoustics. The society also holds two major scientific meetings each year. See https://acousticalsociety.org/.

Using ultrasound as an antibody in Alzheimer’s and as a drug dose enhancer in cancer patients

Elisa Konofagou – ek2191@columbia.edu

Columbia University, 1210 Amsterdam Ave, New York, New York, 10027-7003, United States

Popular version of 2aBAa1 – Neuronavigated focused ultrasound for clinical bbb opening in alzheimer’s and brain cancer patients
Presented at the 184 ASA Meeting
Read the abstract at https://doi.org/10.1121/10.0018295

Ultrasound is widely known as an imaging modality in obstetrics and cardiology as well as several other applications but less known regarding its therapeutic effects despite its recent approvals in the clinic for ablation of prostate cancer and essential tremors. In the studies presented, we demonstrate that focused ultrasound (FUS) can be used in conjunction with microbubbles to open the blood-brain barrier (BBB) through the intact scalp of Alzheimer’s and pediatric tumor patients. The BBB is the main defense of the brain against toxic molecules but also prevents drugs from treating brain disease. In the case of Alzheimer’s, we demonstrate for the first time that the BBB opening resulting from FUS in the prefrontal cortex acts as an antibody in the brain. BBB opening results into a beneficial immune response in the brain that significantly reduces the beta amyloid in the region where ultrasound opened the blood-brain barrier. This was shown in 5 patients with Alzheimer’s.

In the case of the pediatric tumor patients, we aimed into the stem, which is a critical region between the spinal cord and the brain. The tumors in the pediatric patients are gliomas that grow in the stem where critical nerve fibers run through and they are therefore inoperable. We showed for the first time that BBB opening can be repeatedly induced with FUS in conjunction with microbubbles safely and efficiently in patients with pediatric glioma tumors in the stem. In this case, we used FUS in conjunction with a drug that, when crossing the blood-brain barrier, increases its efficiency. The patients reported smoother limb movement after treatment with the drug potentially acting more potently on the tumor.

It was concluded that ultrasound can safely open the blood-brain barrier in both patients as young as 6 years old to as old as 83 years old completely noninvasively and more importantly reduce the disease pathology and/or symptoms. The system is thus versatile, does not require a dedicated MR system or to be performed in the MR scanner unlike other systems and the entire procedure can last less than 30 min from start to finish. Ultrasound can thus be used alone or in conjunction with a drug in order to change the current dire landscape of treatment of brain disease. Finally, we show how Alzheimer’s beta amyloid and tau are excreted from the brain and can be detected with a simple blood test.